We are live on
!
Find out more
Supernus Pharmaceuticals
SUPN
SUPN
258 hedge funds and large institutions have $2.01B invested in Supernus Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 88 increasing their positions, 98 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 263 → 258 (-5)
10% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 98
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
258
Holding in Top 10
3
Calls
$2.92M
Puts
$91K
Top Buyers
| 1 | +$14.9M | |
| 2 | +$14.2M | |
| 3 | +$14.2M | |
| 4 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
+$11.1M |
| 5 |
Renaissance Technologies
New York
|
+$5.11M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$13.5M | |
| 3 | -$11.1M | |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$9.89M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
-$8.59M |